Dipexium Pharmaceuticals (DPRX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts DPRX Hot Sheet
Join SI Premium – FREE
Dipexium Pharmaceuticals (NASDAQ: DPRX) reported Q2 EPS of ($0.47), $0.04 worse than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Dipexium Pharmaceuticals (DPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
